PKBO
Peak Bio, Inc. Common Stock
PKBO
PKBO
Delisted
PKBO was delisted on the 9th of January, 2023.
1 hedge funds and large institutions have $314K invested in Peak Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 8 closing their positions.
Holders
1
Holders Change
-8
Holders Change %
-88.89%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PAI
1
Palo Alto Investors
Palo Alto,
California
| $314K | 497,528 | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| – | – | -51,092 | Closed |
|
3
Charles Schwab
San Francisco,
California
| – | – | -38,631 | Closed |
|
4
Northern Trust
Chicago,
Illinois
| – | – | -14,382 | Closed |
|
5
Goldman Sachs
New York
| – | – | -13,716 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | – | -3,161 | Closed |
|
7
UBS Group
Zurich,
Switzerland
| – | – | -719 | Closed |
|
8
Morgan Stanley
New York
| – | – | -278 | Closed |
|
9
Wells Fargo
San Francisco,
California
| – | – | -49 | Closed |
|
|
CFGS
10
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|